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Innate immune sensors are required for induction of
pathogen-specific immune responses. Retroviruses
are notorious for their ability to evade immune
defenses and establish long-term persistence in
susceptible hosts. However, some infected animals
are able to develop efficient virus-specific immune
responses, and thus can be employed for identifica-
tion of critical innate virus-sensing mechanisms.
With mice from two inbred strains that control
retroviruses via adaptive immune mechanisms, we
found that of all steps in viral replication, the ability
to enter the host cell was sufficient to induce
antivirus humoral immune responses. Virus sensing
occurred in endosomes via a MyD88-Toll-like
receptor 7-dependent mechanism and stimulated
virus-neutralizing immunity independently of type I
interferons. Thus, efficient adaptive immunity to
retroviruses is induced in vivo by innate sensing of
the early stages of retroviral infection.INTRODUCTION
The demand for producing highly efficient vaccines against
human immunodeficiency virus (HIV) is great. However, the
approaches for making vaccines currently available may not be
relevant to retroviral infections, because none of the trials con-
ducted to date have succeeded. A basic understanding of how
the immune system detects and responds to retroviruses must
be gained first in order to apply this knowledge to the production
of antiretrovirus vaccines.
A required step in the development of a pathogen-specific
protective immune response (Medzhitov and Janeway, 1997) is
the recognition of pathogen-associated molecular patterns
(PAMPs) by pattern recognition receptors (PRRs). PAMPs repre-
sent highly conservedmicrobial molecular structures that are not
found in the host cells or in the compartment of infected cells in
which the pathogen replicates. Bacterial pathogens are detected
by Toll-like receptors (TLRs), which recognize bacterial lipids,
peptidoglycans, or proteins that are foreign to eukaryotic cells
(Medzhitov, 2007). Unlike bacterial cell surfaces, viral exteriors
lack specific structures that can distinguish them from the
surfaces of eukaryotic cells. Consequently, viral recognitionoccurs through cytosolic or endocytic PRRs that detect virally
produced replication intermediates (e.g., various forms of
nucleic acids) (Kawai and Akira, 2010) or through inflamma-
somes, which detect the activities of some virally encoded
proteins (Ichinohe et al., 2010). Although many viral sensors
have been identified in vitro, very few of these have been proven
to play an essential role in virus sensing in vivo (Kawai and Akira,
2010). In some instances, viral sensors identified in vitro were
shown to be dispensable for generation of effective antiviral
immune responses in vivo (Ammann et al., 2009; Bhoj et al.,
2008; Edelmann et al., 2004). Therefore, sensing documented
in vitro cannot be accepted as meaningful without the scrutiny
of in vivo experiments, making animal models essential for eval-
uating the requirements and consequences of virus sensing.
Various retroviral replication intermediates can potentially be
recognized by the innate immune system. The question is: which
sensors are important for a successful adaptive immune
response? To address this, it is critically important to select
the most appropriate in vivo model system. Most mouse strains
are susceptible to various retroviruses, making them ineffective
for identification of retrovirus-sensing mechanisms. In contrast,
mice that are genetically resistant to retroviruses are able to
initiate and maintain robust antiviral responses. Because adap-
tive immune responses require an innate immune trigger, genetic
inactivation of virus-detection mechanisms should result in
complete loss of resistance in these animals. If the sensing
mechanisms were to be identified in these mice, they would
probably be shared with other vertebrate species, because
retroviruses use the same replication strategy in all vertebrates.
Therefore, we consider retrovirus-resistantmice to be a natural
choice for addressing the three outstanding issues concerning
retrovirus-specific immunity: is viral replication required for
induction of a virus-specific immune response? What are the
necessary and sufficient steps in the viral replication cycle that
trigger this response? And what is the nature of the PRR(s) that
senses retroviral pathogens?
Retroviruses from two distinct genera were used to search for
retrovirus-sensing mechanisms: mouse mammary tumor virus
(MMTV; a betaretrovirus) and murine leukemia virus (MuLV;
a gammaretrovirus). MMTV is transmitted as an exogenous virus
passed either through the milk of lactating females or as an
endogenous stably integrated provirus (Coffin, 1990). Lymphoid
cells are the first targets of infection; they then spread the virus to
the mammary glands, leading to tumor development. MuLV is
also transmitted via both exogenous and endogenous routes
(Rosenberg and Jolicoeur, 1997). Exogenous MuLV is passed
through the blood andmilk and primarily infects cells of lymphoidImmunity 35, 135–145, July 22, 2011 ª2011 Elsevier Inc. 135
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succumb to leukemia.
Mice from retrovirus-susceptible strains detect retroviral path-
ogens, as indicated by the fact that they initiate an antiretroviral
response. However, this response is not long lasting and is
unsuccessful in controlling virus replication (Chesebro et al.,
1990; Purdy et al., 2003), which is probably due to the numerous
mechanisms of immune evasion employed by retroviruses
(Dittmer et al., 2004; Evans and Desrosiers, 2001; Jude et al.,
2003; Malim and Emerman, 2008). In contrast, pathogen detec-
tion in resistant mice translates into a robust, long-lasting, and
virus-neutralizing immune response (Chesebro et al., 1990;
Purdy et al., 2003).
Two retrovirus-resistant mouse models were chosen for
studying mechanisms of retrovirus detection. Mice from these
strains become infected but mount powerful antivirus immune
responses that either eliminate the virus or efficiently control viral
replication and transmission. C57BL/6J (B6) mice infected with
MuLV eliminate the virus through a dominant mechanism that
includes humoral and cell-mediated responses (Miyazawa
et al., 2008). Antiretroviral production of antibody (Ab) in B6
mice is mediated by the single dominant gene, recovery from
Friend virus 3 (rfv3), mapped to chromosome 15 (Hasenkrug
et al., 1995). Two closely linked genes have been recently impli-
cated as candidates for rfv3: deoxycytidine deaminase Apobec3
(Santiago et al., 2008, 2011) and B cell-activating factor receptor
(Tnfrsf13c) (Tsuji-Kawahara et al., 2010).
Although B6 mice are resistant to MuLV, they are susceptible
to MMTV (Buggiano et al., 1999; Wrona and Dudley, 1996). In
contrast, mice from the I/LnJ strain are the only known inbred
mice capable of controlling both MMTV and MuLV infections
via Ab (Case et al., 2005; Purdy et al., 2003) and cell-mediated
responses (Case et al., 2008; Kane et al., 2011). The mechanism
of resistance inherited by I/LnJ mice is recessive and is mapped
to a single locus on chromosome 17 (Case et al., 2008; Golov-
kina, 2000). The gene within this locus responsible for retroviral
resistance is yet to be identified.
It is necessary to emphasize that a knowledge of the specific
mechanisms underlying antiviral immune responses in resistant
mice is not required for identification of retrovirus innate immune
sensor(s), because these mechanisms operate downstream
of virus detection events. Consequently, abrogation of innate
immune sensing is expected to reverse the resistance phenotype
and provide a straightforward readout of retroviral detection.
With these retrovirus-resistance mice, we found that endosomal
Toll-like receptor 7 (TLR7) is an innate immune receptor that
detects retroviruses.
RESULTS
Antiretroviral Responses against MMTV
As previous studies have shown, retrovirus-resistant I/LnJ mice
do not react against their endogenousMMTVs (Case et al., 2008;
Purdy et al., 2003). The unresponsiveness to endogenous
viruses may be explained by immunological tolerance. Alterna-
tively, it could be due to the lack of specific stimuli associated
with the replicating retroviral pathogen, because the vast
majority of endogenous viruses are defective or silent (Boeke
and Stoye, 1997).136 Immunity 35, 135–145, July 22, 2011 ª2011 Elsevier Inc.Endogenous Mtv7 and Mtv17 inherited by I/LnJ mice (Mac-
Dearmid et al., 2006) are unable to produce infectious virions
because of premature stop codons in their env genes (the
Mouse Genome Project [http://www.sanger.ac.uk/Projects/
M_musculus/] and data not shown). To determine whether
a replication-competent endogenous virus is required for induc-
tion of an antivirus immune response in I/LnJmice,we introduced
a new MMTV provirus capable of producing infectious virions,
termed hybrid provirus (HP) (Shackleford and Varmus, 1988), as
a transgene into the I/LnJ genome (I/LnJ-HP mice) (see Fig-
ure S1A available online). The HP transgene encodes a T cell
receptor (TCR) Vb14-specific superantigen (SAg) and thus
causes negative selection of Vb14+ T cells (Golovkina et al.,
1994). As expected, SAg-cognate T cells were deleted in I/LnJ-
HP mice (0.53% ± 0.4% [n = 10] of Vb14+ T cells among CD4+
Tcells in transgenic versus 8.79%±1.0% [n=8] in nontransgenic
mice). I/LnJ-HP mice produced infectious virions, as shown by
the fact that viral RNA was present in the milk of I/LnJ-HP mice
(Figure S1B) and newly integrated HP proviruses were present
in the splenic DNA (Figure S1C).
To test whether I/LnJ mice are capable of responding to
infectious virus produced from the endogenous HP transgene,
sera from I/LnJ-HP multiparous females (MMTV expression is
controlled by lactogenic hormones) (Golovkina et al., 1995;
Yamamoto, 1985) were analyzed for the presence of Abs reac-
tive with MMTV virion proteins. Whereas I/LnJ-HP mice
produced virus-specific Abs, nontransgenic I/LnJ mice did not
(Figures 1A and 1B). Because the production of virus-specific
Abs was similar in I/LnJ-HP mice fostered by either HP trans-
genic or nontransgenic females, the response did not require
HP transmission through milk, but rather was induced by infec-
tion with the virus encoded by the transgene. The neutralizing
Ab response was specific to virus-resistant I/LnJ-HP mice, as
shown by the fact that virus-susceptible HP transgenic (C3H/
HeN-HP) mice did not respond to the virus (Figure 1A).
In I/LnJ mice infected with exogenous MMTVs, virus transmis-
sion to the offspring is abolished, because virions secreted into
the milk are coated with Abs (Purdy et al., 2003). Abs produced
by I/LnJ-HP females were also virus neutralizing, and mice
fostered by these females remained uninfected (Figure 1C).
Thus, I/LnJ-HP mice were capable of mounting a neutralizing
response against an infectious virus produced by a replication-
competent endogenous provirus.
Activation of the innate system produces three different
signals that are required for the initiation of adaptive immune
responses: active antigen processing and presentation, costi-
mulation, and cytokine production. These signals can be
upregulated by external adjuvants, often used for vaccine
production. The data presented thus far suggested that repli-
cating virus could substitute for the external adjuvant. To test
whether denatured virus retains adjuvant properties, I/LnJ mice
were injected with heat-inactivated virions in either the presence
or absence of Complete Freund’s Adjuvant (CFA). Immunization
of I/LnJ mice with heat-inactivated virus in CFA resulted in
production of virus-specific Abs, similar to the response to infec-
tion with biologically active virus (Figure 1D). However, I/LnJ
mice injected with heat-inactivated virus in the absence of CFA
were unresponsive (Figure 1D). Thus, although infectious virus
is able to upregulate adaptive immunity in the absence of an
Figure 1. Endogenous Replication-Competent
MMTV Elicits Antivirus Immune Responses in
Retrovirus-Resistant Mice
(A) Serum samples from I/LnJ, I/LnJ-HP, and control C3H/
HeN-HP multiparous females were tested for reactivity
against MMTV virion proteins by ELISA. Because the
virus-specific humoral immune response in I/LnJ mice is
IFN-g mediated (Purdy et al., 2003), anti-mouse IgG2a-
specific Abs coupled to AP were used at the second step.
OD 405: optical density at 405 nm. Nine mice per each
group were tested.
(B) PVDF strips with separated virion proteins were incu-
bated with mouse monoclonal Abs against capsid Gag
(ap27Gag), transmembrane Env (agp36Env), surface Env
(agp52Env), or indicated mouse sera. Anti-mouse poly-
isotypic Abs (for monoclonal Abs) or anti-mouse IgG2a-
specific Abs coupled to horseradish peroxidase (HRP)
were used at the second step. Numbers correspond to
individual mice.
(C) Frequencies of peripheral Vb14+ T cells among CD4+
T cells were determined in 10-week-old virus-susceptible
mice fostered by either I/LnJ-HP or control C3H/HeN-HP
females by FACS. Each symbol represents one mouse.
None of more than 50 individual C3H/HeN-HP transgenic
females tested produced uninfected animals.
(D) Sera from I/LnJ mice injected with either heat-inactivated or biologically active virus were tested for reactivity against MMTV virion proteins by ELISA. In
parallel, a group of I/LnJ mice was immunized with heated MMTV virions in CFA. Anti-mouse IgG2a-specific Abs coupled to AP were used at the second step.
Three to four mice were used per group in two independent experiments.
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this response.
Antiretroviral Responses against MuLV
In addition to endogenous MMTVs, the mouse genome contains
multiple copies of endogenous MuLVs, which are classified as
ecotropic, xenotropic, or polytropic mink cell focus forming
(MCF) viruses based on their receptor usage (Risser et al.,
1983). Although many endogenous MuLVs are defective, some
are capable of producing infectious particles (Cloyd et al.,
1980; Hook et al., 2002; Stoye et al., 1991). I/LnJ mice inherit
endogenous MuLVs (Figure S2A), and ecotropic viruses were
upregulated in aged I/LnJ mice, as evidenced by the presence
of infectious virions in their spleens (Table 1). To determine
whether these replication-competent endogenous MuLVs were
proficient in inducing an Ab response akin to that triggered by
endogenous replication-competent MMTVs, we investigated
anti-MuLV responses in aged I/LnJ mice. All MuLV-shedding
I/LnJ mice produced virus-specific Abs (Table 1; Figure 2A).
Importantly, the ability to produce Abs was not dependent on
the virus titer, as shown by the fact that both high and low
virus producers were able to mount a virus-specific response
(Table 1). The Abs were directed against major virion proteins
(Figure 2B). Similar to responses against exogenous retroviruses
(Purdy et al., 2003), humoral responses against endogenous
viruses were dependent on IFN-g (Table 1; Figure 2).
We then asked whether virus derived from infectious endoge-
nous provirus is capable of inducing an immune response when
introduced as an exogenous virus. Accordingly, we injected
young I/LnJ mice with virions harvested from SC-1 cells cocul-
tured with virus-shedding splenocytes derived from aged I/LnJ
mice (Figure S2B). All I/LnJ mice that received the virus mounted
antiviral humoral immune responses (Figure S2C). Thus, virus-resistant mice are not tolerant to endogenous retroviruses, but
require some step(s) of the viral replication cycle in order to acti-
vate an antivirus immune response.
Endosomal Uptake of Nonreplicating Virus Stimulates
an Immune Response in Virus-Resistant Mice
Both MuLV and MMTV enter via receptor-mediated endocytosis
(Katen et al., 2001; Wang et al., 2008). To investigate whether
viral entry is sufficient for activation of virus-specific immune
response, we used UV irradiation, a treatment that blocks repli-
cation of RNA viruses but does not affect their entry (Bender
et al., 1995; Ogura, 1976). Likewise, both live and UV-irradiated
MMTV and MuLV entered endosomes (Figure 3A; Figure S3A).
To determine whether viral entry is sufficient for induction of
antiretroviral immunity, we injected I/LnJ mice with live or UV-
irradiated MMTV or MuLV virions. As expected, UV irradiation
abolished virus infectivity, because injected mice did not show
deletion of SAg-cognate T cells (Figure 3B) and did not contain
newly integrated exogenous proviruses in their spleens (data
not shown). UV irradiation also rendered MuLV noninfectious,
as shown by the fact that susceptible BALB/cJ mice injected
with UV-irradiated MuLV virions did not become infected (Fig-
ure 3C). Within 6 weeks of injection, virus-specific Abs became
evident in mice injected with either live or UV-irradiated virus
(Figures 3B and 3C). The Ab response was seen only in virus-
resistant I/LnJ mice, whereas virus-susceptible C3H/HeN and
BALB/cJ mice did not respond to UV-irradiated virus, indicating
that Ab production by I/LnJ mice was not a result of immuniza-
tion (Figures S3B and S3C). Collectively, these results demon-
strate that the ability to enter the host cell is sufficient to induce
an antivirus humoral immune response, because equivalent
starting titers of UV-irradiated and live virus were comparably
immunogenic.Immunity 35, 135–145, July 22, 2011 ª2011 Elsevier Inc. 137
Table 1. Production of Infectious Ecotropic MuLV by BALB/cJ
and I/LnJ Lymphocytes
Mice Age ODa PFU/107 Cellsb
BALB/cJ >150 days 0.0 44
0.0 0
0.0 145
0.0 44
0.0 141
0.0 0
0.0 49
I/LnJ <90 days 0 (n = 10) 7 ± 4 (n = 3)
I/LnJ >150 days 1.3 204
0.7 22
0.3 31
0.3 572
0.2 78
0.1 508
0.1 84
I/LnJ Ifng/ >120 days 0 (n = 6) 467 ± 64 (n = 6)
Abbreviations: PFUs, plaque forming units; n, number of mice used; ND,
nondetermined.
aOptical density (OD) at 405 nm obtained with mouse sera minus OD
obtained with secondary Ab alone in MuLV-specific ELISA. Animals are
ranked from high to low Ab producers.
b Spleen cells from BALB/cJ, I/LnJ, and I/LnJ Ifng-deficient (Ifng/) mice
were subjected to an infectious center assay.
Figure 2. Infectious Virus Produced by Endogenous MuLVs Stimu-
lates an Antiviral Response
(A) Serum samples fromBALB/cJ, I/LnJ, and I/LnJ Ifng/mice were tested for
reactivity against MuLV virion proteins by ELISA. Sixmice per each groupwere
tested.
(B) Serum samples were tested for reactivity against MuLV virion proteins by
immunoblot. gp70Env, surface glycoprotein, product of the env gene; p30Gag,
capsid protein, product of the gag gene; p25Gag, immature capsid protein,
product of the gag gene. Numbers correspond to individual mice.
Anti-mouse IgG2a-specific Abs coupled to HRP were used at the second step
for all but I/LnJ Ifng/mice for which anti-mouse polyisotypic Abs coupled to
HRP were utilized.
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Controls MMTV-Specific Ab Responses
Because nonreplicating entry-competent retrovirus was capable
of inducing an immune response, we reasoned that an endoso-
mal PRR(s) would be sensing the pathogen. Three sensors are
localized within the endosomal compartment: TLR3, TLR9, and
TLR7, which detect dsRNA, DNA, and ssRNA, respectively.
Whereas TLR3 signals via a MyD88-independent mechanism,
both TLR7 and TLR9 require MyD88 for signal transduction
(Kawai and Akira, 2010). We first tested whether a TLR3-medi-
ated innate immune mechanism underlies retrovirus-specific
Ab responses in virus-resistant mice. TLR3 signals via an IRF-
3-dependent mechanism (Kawai and Akira, 2010), and this
signaling mechanism is ablated in both Tlr3/ and Irf3/
mice (Alexopoulou et al., 2001; Sato et al., 2000). Accordingly,
Tlr3/ I/LnJ mice and Irf3/ B6 mice infected with MMTV or
MuLV, respectively, were screened for retrovirus-specific Abs.
Animals from both groups responded to retroviruses by pro-
ducing virus-specific Abs (Figures 4A and 4B), indicating that
TLR3 is dispensable for the retroviral detection that controls
antivirus humoral immune responses. These data suggested
that a MyD88-dependent receptor(s) must be the retrovirus
sensor in the endosome.
Previously, Browne and Littman (2009) established that
MyD88 is required for neutralizing Ab responses against MuLV
in B6mice. To extend these findings to another retroviral system,
we used MMTV-resistant I/LnJ mice. Unlike MMTV-infected
wild-type (WT) I/LnJ mice, infected Myd88/ I/LnJ mice failed
to produce virus-specific Abs (Figure 5A) nor did virus-exposed138 Immunity 35, 135–145, July 22, 2011 ª2011 Elsevier Inc.Myd88/ splenocytes secrete proinflammatory cytokines (Fig-
ure S4A). Together these data indicate that MyD88 is required
for MMTV-mediated production of proinflammatory cytokines
and virus-specific Abs.
To identify which of the two MyD88-dependent endosomal
PRRs detects retroviruses, we infected retrovirus-resistant
mice with deficiency in either TLR9 or TLR7. BothMuLV-infected
Tlr9+/+ and Tlr9/ B6 mice produced virus-specific Abs and
cleared the virus (Figure S4B), indicating that TLR9 is not
required for Ab-mediated control of retroviral infections. TLR7
is an endosomal MyD88-dependent PRR, which detects ssRNA
(Diebold et al., 2004), and is therefore a likely candidate for
a retroviral sensor. To determine whether TLR7-MyD88-medi-
ated signaling is indeed the basis for detection of retroviral
pathogens, we infected Tlr7/ B6 and I/LnJ mice with MuLV
and monitored them for antiviral immune responses. Although
WT B6 and I/LnJ mice were able to efficiently control infection,
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Restriction of viral replication in WT mice correlated with the
production of virus-specific Abs (Figure 5B).
To determine whether recognition of MMTV infection is also
TLR7 dependent, we infected Tlr7/ I/LnJ and B6vic1I/LnJ mice
(congenic B6 mice that carry the vic1 region from I/LnJ mice
responsible for virus control) (Figure S5A) with MMTV and moni-
tored them for virus-specific Ab production. Whereas WT I/LnJ
and B6vic1I/LnJ mice mounted anti-MMTV humoral responses
(Figure 5C; Figure S5B) and class-switched to an IgG2a- or
IgG2c-specific response (not shown and Figure S5B), Tlr7/
mice of both backgrounds did not produce virus-specific Abs
of any isotype (Figure 5C; Figure S5B). These data indicate
that retroviruses are detected via a TLR7-dependent mechanism
and that this detection leads to an antivirus humoral immune
response.
Type I IFNs Are Dispensable for Antiretroviral
Humoral Responses
Stimulation of TLR7 results in upregulation of both type I IFNs (via
interferon regulatory factor 7 [IRF7]) and inflammatory cytokines
(via NF-kB) (Kawai and Akira, 2010). Type I IFNs have been impli-
cated as crucial factors for antiviral immunity in the early stages
of MuLV infection (Gerlach et al., 2006). To address whether
type I IFNs contribute to protective antiretrovirus immunity, we
infected IFN-ab receptor 1-deficient (Ifnar1/) B6 mice with
MuLV and compared their antivirus response to the response
generated by infected WT B6 mice. Ifnar1/ B6 mice produced
antiretroviral Abs and cleared viral infection similarly to WT B6
mice (Figure 6). These results indicate that type I IFNs are not
essential for the production of antiretroviral neutralizing Abs.
DISCUSSION
Most retroviral infections result in indefinite viral persistence with
an undetectable or inefficient antivirus immune response. Host
failure to clear retroviral infections is probably due to the unique
ability of retroviruses to evade or extinguish host immunity
(Johnson and Desrosiers, 2002; Jude et al., 2003; Schneider-
Schaulies and Dittmer, 2006), rather than the inability to detect
infection. However, this lack of virus-neutralizing responses
makes the identification of retroviral sensors in susceptible indi-
viduals an unachievable goal. To overcome this obstacle, we
utilized mice from retrovirus-resistant strains, in which innate
immune detection is translated into efficient virus-neutralizing
immune responses. We found that replicating exogenous retro-
virus did not require an external adjuvant to stimulate an antivirus
immune response, and endogenous retroviruses (MMTV and
MuLV) were capable of inducing the response as long as infec-
tious virions were produced. Importantly, complete replication
was dispensable for triggering of the sensor, as shown by the
fact that UV-treated virions were still capable of upregulating
the response. Thus, viral entry was documented as the critical
step essential for induction of antiretroviral immunity.
Our findings pointed at the endosome as themost likely site for
innate recognition of the retroviruses. Subsequent experiments
revealed that TLR7 is in fact the retrovirus-sensing receptor, as
indicated by the fact that MuLV- or MMTV-infected Tlr7/ retro-
virus-resistant mice did not produce virus-specific Abs andfailed to clear infection. TLR7 is expressed in plasmacytoid
dendritic cells (pDCs), CD11b+ DCs, and B cells (Iwasaki and
Medzhitov, 2004). This receptor senses ssRNA derived from
RNA viruses such as orthmyxoviruses (influenza A virus) (Diebold
et al., 2004), paramyxoviruses (Sendai virus, SeV) (Lee et al.,
2007), rhabdoviruses (vesicular stomatitis virus, VSV) (Lund
et al., 2004), and arteriviruses (lactate dehydrogenase-elevating
virus, LDV) (Ammann et al., 2009), and also from retroviruses
(HIV) (Beignon et al., 2005; Hardy et al., 2007). Signaling through
TLR7 triggered by these viruses induces secretion of type I IFNs
and of proinflammatory cytokines as determined by in vitro
and in vivo studies. However, one must exercise caution when
addressing the role of PRR signaling in antiviral responses in
vivo. For example, strong TLR7-dependent upregulation of
type I IFNs by LDV appears to be completely dispensable for
controlling virus replication in vivo (Ammann et al., 2009). The
end-point of antiviral responses in retrovirus-resistant mice used
in our study was viral clearance/control, so our results provide
definitive evidence that TLR7-dependent recognition is required
for an efficient immune response against retroviruses in vivo.
Our results further demonstrate that type I IFNs are not
required for protective antiviral immunity and ultimate virus clear-
ance. Although our experiments do not address the role for type I
IFNs in the early stages of infection, they do suggest that produc-
tion of type I IFNs is not an adequate read-out for the induction of
antiviral adaptive immune responses, because they are dispens-
able for the control of retroviral infection in vivo.
Identification of viral PRR ligands in in vitro experiments has
created an oversimplified view of innate sensing of viral patho-
gens, because these studies assume that viral nucleic acids
are abundant in the compartments in which the sensors are
located. The major problem with this assumption is that viral
replication is tightly regulated and viral nucleic acids are pro-
tected from exposure to cellular factors by various means.
Both viral RNA and unintegrated DNA reside within a protein
core, termed preintegration complex (PIC), and are isolated
from cellular factors and/or sensors at all times during the virus’
journey from the cell membrane to the nucleus. Only when the
PIC reaches the nucleus does it become accessible by other
proteins (Bowerman et al., 1989). How then is the viral RNA being
sensed by endosomal TLR7? Because there is no evidence doc-
umenting degradation of viral particles in endosomes prior to
viral RNA release, we favor other potential explanations. One
possibility is related to defective viral particles that enter cells
but fail to complete the life cycle. Indeed, it has been estimated
that only 10% of retroviral particles in a viral stock are able to
productively infect cells (Andreadis et al., 2000). Thus, it is plau-
sible that some defective virions enter cells and fuse with endo-
somes but fail to release their RNA into cytosol. Alternatively,
cells that express TLR7 may somehow uniquely support the
release of viral RNA into endosomes. The precise mechanism
of retroviral RNA exposure to TLR7 is yet to be identified.
Immune control of retroviruses in virus-resistant B6 and I/LnJ
mice requires both neutralizing Ab- and cell-mediated responses
(Miyazawa et al., 2008). AlthoughMuLV-infected B6.Tlr7/mice
failed to raise a sustained antivirus Ab response, they did not
develop splenomegaly by 12 weeks after infection (a phenotype
controlled partly by cell-mediated responses), suggesting that
cell-mediated responses were unaffected by TLR7 deficiencyImmunity 35, 135–145, July 22, 2011 ª2011 Elsevier Inc. 139
Figure 3. Retroviral Entry Is Necessary and Sufficient to Stimulate an Antivirus Immune Response
(A) Live or UV-irradiated MMTV or MuLV were incubated with NMuMG or XC cells, respectively. Cells were stained with Abs against the late endosomal marker
Rab7 (green) and respective viral Gag proteins (red). Top: Maximum intensity 3D reconstruction of z-stacks. Middle: Enlarged single 0.2 mM thick optical slices of
boxed areas. Asterisks indicate colocalization of viral Gag and Rab7; corresponding images with orthogonal views (XZ projection) are shown below. Bottom:
Uninfected cells and cells infected with live virus were stained with Abs against Gag (red). In all panels, nuclei were stained with DAPI (blue). Three independent
experiments were performed.
(B and C) I/LnJ mice were injected with live or UV-irradiated MMTV (B) or MuLV (C). Deletion of SAg-cognate CD4+Vb14+ T cells (shown as percent of all CD4+
T cells) was used as a read-out for MMTV infectivity. ELISA was utilized to screen sera for Abs reactive against virion proteins.
(B) In experiment 1, mice were analyzed 2 weeks after injection; in experiment 2, mice were analyzed at 2–6 weeks after injection (6 week time-point is
shown).
Immunity
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Figure 4. Antivirus Humoral Responses Are Not
TLR3 Dependent
(A) Tlr3/ and Tlr3+/+ I/LnJ mice were fostered on MMTV-
infected C3H/HeN females. Sera from fostered mice were
tested for reactivity against MMTV virion proteins by
ELISA and/or immunoblot at 10 weeks of age. Mice in
experiment 1 (left) were from N7 intercross, whereas mice
in experiment 2 (right) were from N10 intercross. In the
second experiment (right), the same serum samples were
subjected to both ELISA and immunoblot (inset, right).
Anti-mouse IgG2a-specific Abs coupled to either AP or
HRP were used at the second step. Numbers correspond
to individual mice whose sera were used for immunoblot.
(B) Sera from MuLV-infected WT B6 and Irf3/ B6 mice
were tested for reactivity against MuLV virion proteins by
immunoblot. Anti-mouse IgG2c-specific Abs coupled to
HRP were used at the second step. a-p30Gag, mono-
clonal Ab against capsid Gag; p65Gag, immature capsid
protein, product of the gag gene; 2 Ab, a strip incubated
with secondary Ab alone. Numbers correspond to indi-
vidual mice used in a single experiment. PFU, virus titers in
spleens (106 cells) 10 weeks after infection.
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regulated by other receptor(s) in addition to TLR7. Further sup-
porting this notion, the cytotoxic T lymphocyte (CTL) response
in MuLV-infected Myd88/ B6 mice was also unchanged
(Browne and Littman, 2009). Similarly, the CTL response against
another ssRNA virus, influenza, is regulated by an additional
unidentified factor(s) distinct from TLR7 (Heer et al., 2007;
Koyama et al., 2007). Thus, it is safe to say that humoral and
cellular responses against retroviruses are stimulated through
distinct groups of innate sensors. In vivo experiments will be
required to reveal other sensingmechanisms that lead to protec-
tive immunity.
As previously discussed, the genetic mechanisms underlying
successful antiviral responses in B6 and I/LnJ mice are distinct.
All mice appear capable of detecting retroviruses because
both retrovirus-susceptible and retrovirus-resistant animals
can initiate antivirus immune responses (Miyazawa et al., 2008;
Purdy et al., 2003). Therefore, mutations within the genes that
function to translate virus detection into beneficial adaptive
immune responses or affect the virus’s ability to evade immune
responses are most likely to underlie resistance phenotypes in
retrovirus-resistant mice.
Most HIV-infected people are able to detect infection, as
shown by the fact that they mount CTL and Ab responses, but
these responses generally do not result in protection against
the virus (Pantaleo and Fauci, 1995). This further supports the
notion that appropriate virus detection does not always lead to
a neutralizing immune response; additional factors are required(C) Ab reactivity against MuLV virion proteins was tested 2weeks after injection (le
second step. None: uninfected I/LnJmice. Bars correspond to individual mice. To
injected with UV-irradiated virus (or live virus as control) and their spleen cells w
tested in a single experiment.to translate this detection into protective responses, as occurs
in the case of HIV ‘‘elite controllers.’’ These elite controllers
represent approximately 1% of all HIV-1 infections (Deeks and
Walker, 2007) and exhibit mechanisms similar to retrovirus-resis-
tant mice: they control viral replication through productive and
sustained antiretroviral immune responses. An understanding
of the genetic mechanisms underlying retroviral resistance will
help to design antiretroviral vaccines that utilize inactivated
viruses combined with targeting of the immune pathways
employed successfully in resistant organisms.EXPERIMENTAL PROCEDURES
Mice
Mice used in this study were bred and maintained at the animal facility of the
University of Chicago. B6, I/LnJ, BALB/cJ, C3.JK-H2j H2-T18b/Sn (C3.JK,
C3H/He mice congenic by the MHC H-2j haplotype to I/LnJ mice), and
B6;129S1-Tlr3tm1Flv/J mice (Alexopoulou et al., 2001) were purchased from
The Jackson Laboratory. B6.Myd88/ mice (Adachi et al., 1998) were
obtained from R. Medzhitov, Yale University. B6.Tlr7/ mice (Hemmi et al.,
2002) were obtained from D. Roopenian, The Jackson Laboratory.
B6.Ifnar1/ mice (Mu¨ller et al., 1994) were obtained from D. Portnoy, Univer-
sity of California at Berkley. B6.Irf3/ mice (Sato et al., 2000) were obtained
fromK. Fitzgerald, University ofMassachusetts. C3H/HeNmicewere originally
purchased from NCI and have been maintained in our colony for more than
12 years. I/LnJ hybrid provirus (HP) transgenic mice were generated by
crossing C3H/HeN HP transgenic mice (Golovkina et al., 1994) to I/LnJ mice
for 10 generations. I/LnJ Ifng/ mice have been previously described (Purdy
et al., 2003). B6;129S1-Tlr3tm1Flv/J mice were crossed to I/LnJ mice for seven
generations, and heterozygous mice were intercrossed to produce I/LnJft). Goat anti-mouse Abs coupled to alkaline phosphatase (AP) were used at the
confirm lack of replication capability of UV-irradiated virus, BALB/cJmice were
ere subjected to XC-PFU test 6 weeks postinjection (right). n, number of mice
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Figure 5. A TLR7-Dependent Mechanism
Detects Retroviruses
(A) WT I/LnJ and Myd88/ I/LnJ mice were i.p.
injected with MMTV. Sera were analyzed for
reactivity against MMTV virion proteins by immu-
noblot 10 weeks after infection.
(B) Sera from RL-MuLV-infected B6 (left) and I/LnJ
(right) mice with indicated genotypes were tested
for reactivity against MuLV virion proteins by
immunoblot 10 weeks after infection. PFU 3 102:
virus titers in mouse spleens (105 cells) 10 weeks
after infection.
(C) WT I/LnJ and Tlr7/ I/LnJ mice were i.p. in-
jected with MMTV. Sera were analyzed for reac-
tivity against MMTV virion proteins by immunoblot
10 weeks after infection.
Goat anti-mouse Abs coupled to HRP were used
at the second step. Numbers correspond to indi-
vidual mice within a single experiment.
Figure 6. Virus Clearance Is Type I IFN Independent
Sera from MuLV-infected B6 mice with indicated genotypes were tested for
reactivity against MuLV virion proteins by immunoblot 10 weeks postinfection.
Anti-mouse IgG2c-specific Abs coupled to HRPwere used at the second step.
PFU, virus titers in spleens (106 cells) 10 weeks after infection. Numbers
correspond to individual mice within a single experiment.
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Retroviral Infection and ImmunityTlr3/mice. I/LnJ mice were crossed to B6.Myd88/mice for eight genera-
tions, and heterozygous N8 mice were intercrossed to generate I/LnJ
Myd88/ mice. B6.Tlr7/ were crossed to I/LnJ mice for four generations.
Heterozygous animals were intercrossed and Tlr7/ mice homozygous for
the I/LnJ alleles of vic1 (Case et al., 2008) and rfv3 (Super et al., 1999) were
selected for experimentation. All imported animals were rederived by standard
embryo transfer at Charles River before introduction to our colony. The studies
described in this paper have been reviewed and approved by the Animal Care
and Use Committee at the University of Chicago.
MMTV Infection and Immunization
Two exogenous MMTV variants were used in these studies. AnMMTV(LA) viral
variant consisting of three different viruses (BALBLA, BALB2, and BALB14,
with Vb6- and 8-, Vb2-, and Vb14-specific superantigens [Sags], respectively)
(Golovkina et al., 1997; Piazzon et al., 1994) was propagated in BALB/cJ and
C3H/HeN mice. Deletion of CD4+Vb6+, CD4+Vb14+, and CD4+Vb2+ SAg-
cognate T cells was used as a readout for MMTV(LA) infection (Purdy et al.,
2003). I/LnJ mice inheritMtv7 and thus do not have Vb6+ T cells (MacDearmid
et al., 2006; Purdy et al., 2003). Consequently, MMTV(LA)-infected I/LnJ mice
were screened for virus infection by following deletion of CD4+Vb14+ and
CD4+Vb2+ T cells among CD4+ T cells. HP is an exogenous MMTV produced
by the HP transgene (Figure S1A; Golovkina et al., 1994; Hook et al., 2000),
which encodes for the Vb14-specific SAg (Choi et al., 1991). As a result,
mice infected with exogenous HP show deletion of CD4+Vb14+ T cells (Hook
et al., 2000).
Mice were infected by either fostering on viremic females or by i.p. injection
of purified virions. For injection, MMTV virions were purified from solidifiedmilk
removed from the stomachs of 2- to 4-day-oldMMTV-infected pups, diluted in
10 volumes of phosphate-buffered saline, and centrifuged at 2000 3 g for
15 min. The cream and pellet were discarded, and the skim milk was injected
at an equivalent of 50 ml of milk per mouse.
In some instances, mice were injected i.p. withMMTV virions heated at 85C
for 10 min, or immunized with 85C heated MMTV virions in CFA (DIFCO) as
previously described (Purdy et al., 2003).142 Immunity 35, 135–145, July 22, 2011 ª2011 Elsevier Inc.MuLV Isolation and Infection
Rauscher-like-MuLV (RL-MuLV) virus mixture has
been described previously (Hook et al., 2002)
and was propagated in SC-1 cells (ATCC) (Case
et al., 2008). Viral titers in supernatants were
determined by an infectious center assay (Rowe
et al., 1970) and mice were injected i.p. with
2 3 104 PFU of virus per mouse.
To test for ecotropic MuLVs, 105 to 107 spleno-
cytes isolated from I/LnJ and BALB/cJ mice
were irradiated at 2000 Rad and subjected to
the infectious center assay. To isolate exogenousvirus produced by the endogenous ecotropic provirus, irradiated splenocytes
from an aged I/LnJmousewere coculturedwith SC-1 cells. Supernatants were
collected from SC-1 cells after four passages. Titers of infectious virus were
determined by infectious center assay. Virus was injected at 2 3 104 PFU
per mouse.
UV Irradiation
Within each experiment, a single viral prep was divided equally into live and
UV-irradiated fractions and the same amount was injected into mice. For UV
Immunity
Retroviral Infection and Immunityirradiation, purified MMTV or MuLV virions were exposed to 72 Ergs/cm2 UV
irradiation for 45 min on ice 25 cm from the source. Live and UV-irradiated
virions were injected i.p. at an equivalent of 50 ml milk (MMTV) and
2 3 104 PFU (MuLV) per mouse.
ELISA
To detect MMTV andMuLV Abs in mouse sera, an enzyme-linked immunosor-
bent assay (ELISA) was performed as previously described (Case et al., 2008;
Purdy et al., 2003). All sera were used at 5 3 103 dilution. Mouse IgG2a-,
IgG2c-specific, or polyisotypic immunoglobulin Abs coupled to alkaline phos-
phatase (AP) or horseradish peroxidase (HRP) were used at the second step
(Southern Biotech; Jackson ImmunoResearch). Backgrounds obtained from
incubation with secondary Abs alone were subtracted.
Immunoblot Analysis
MMTV virions were isolated from themilk as previously described (Purdy et al.,
2003). MuLV virions were isolated from supernatants of infected SC-1 cells via
centrifugation at 95,000 3 g. MMTV and MuLV virion proteins were electro-
phoresed on 15% polyacrylamide gels under reducing conditions, transferred
to polyvinylidene fluoride (PVDF) membranes (Bio-Rad), and incubated with
sera or monoclonal Abs. All sera were used at 5 3 103 dilution. Anti-Env
and anti-GagMMTVmonoclonal Abs (Purdy et al., 2003) were used as positive
controls for the MMTV-specific immunoblot. Anti-p30CA, a rat monoclonal Ab
against p30CAGag (ATCCCRL-1912, generous gift ofW.Mothes, Yale Univer-
sity) was used as control for MuLV-specific immunoblots. For monoclonal Abs,
anti-mouse or anti-rat polyisotypic Abs coupled to HRP were used at the
second step. For sera, either mouse IgG2a-, IgG2c-specific, or polyisotypic
immunoglobulin Abs coupled to HRP were used at the second step (Southern
Biotech; Jackson ImmunoResearch; Bio-Rad). Blots were developed with
immunoblot detection reagents (GE Healthcare Life Sciences).
Immunofluorescence
NMuMG (ATCC #CRL-1636) or XC (ATCC #CCL-165) cells seeded on Cultur-
eWell 8-well Coverslips (Sigma-Aldrich) were incubated with live or UV-treated
MMTV (purified from 10 ml milk) or MuLV (1 3 105 PFU), respectively, for
90 min at 4C, then shifted to 37C for 15 min (as previously described by
Wang et al., 2008). Cells were then fixed with 4% paraformaldehyde in PBS
for 15 min and permeabilized with 0.2% Triton X-100. After blocking with
30% sheep-serum, cells were incubated with primary and secondary Abs
and mounted on DAPI-containing mounting medium (Invitrogen).
For detailed methods, please refer to Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at doi:10.1016/
j.immuni.2011.05.011.
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